Followers | 32 |
Posts | 1273 |
Boards Moderated | 0 |
Alias Born | 06/12/2011 |
Friday, November 03, 2023 2:28:42 PM
(5)
PatSnap
https://synapse.patsnap.com › drug
MCT-175: Drug Targets, Indications, Patents
Oct 1, 2023 - MCT-175, Initially developed by MultiCell Technologies, Inc., Now, its global highest R&D status is Pending,..
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM